Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Inventory (2016 - 2020)

Plus Therapeutics has reported Inventory over the past 11 years, most recently at $107000.0 for Q3 2020.

  • Quarterly Inventory changed 0.0% to $107000.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $107000.0 through Sep 2020, changed 0.0% year-over-year, with the annual reading at $107000.0 for FY2019, 0.0% changed from the prior year.
  • Inventory was $107000.0 for Q3 2020 at Plus Therapeutics, roughly flat from $107000.0 in the prior quarter.
  • Over five years, Inventory peaked at $4.5 million in Q2 2016 and troughed at $107000.0 in Q4 2018.
  • The 5-year median for Inventory is $3.0 million (2018), against an average of $2.3 million.
  • Year-over-year, Inventory increased 11.15% in 2016 and then tumbled 96.64% in 2018.
  • A 5-year view of Inventory shows it stood at $3.7 million in 2016, then decreased by 14.55% to $3.2 million in 2017, then tumbled by 96.64% to $107000.0 in 2018, then changed by 0.0% to $107000.0 in 2019, then changed by 0.0% to $107000.0 in 2020.
  • Per Business Quant, the three most recent readings for PSTV's Inventory are $107000.0 (Q3 2020), $107000.0 (Q2 2020), and $107000.0 (Q1 2020).